Texaclear

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of symptoms associated with the common cold, hay fever (allergic rhinitis), or other upper respiratory allergies. The symptoms alleviated by this medication include runny nose, itchy and watery eyes, itching of the nose or throat, sneezing, and cough due to minor throat and bronchial irritation.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 12 years and older are advised to take 1 tablet every 6 to 8 hours as needed. The maximum dosage should not exceed 4 tablets within a 24-hour period.

This medication is not recommended for use in children under 12 years of age.

Contraindications

Use of this product is contraindicated in patients who consume alcoholic beverages. The concomitant use of alcohol, sedatives, or tranquilizers may enhance drowsiness, posing a risk to patient safety.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this product.

Patients should be advised to consult a physician prior to use if they have any of the following conditions: a chronic cough, such as that associated with smoking, asthma, or emphysema; a cough accompanied by excessive phlegm; glaucoma; a respiratory condition like emphysema or chronic bronchitis; or difficulty urinating due to prostate gland enlargement. Additionally, it is important to seek guidance from a healthcare provider or pharmacist if the patient is currently taking sedatives or tranquilizers.

While using this product, certain general precautions should be observed. Users may experience excitability, particularly in children, and marked drowsiness may occur. It is recommended to avoid the consumption of alcoholic beverages, as alcohol, sedatives, and tranquilizers can exacerbate drowsiness. Caution is advised when driving or operating machinery due to the potential for impaired alertness.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should discontinue use and consult a physician if they experience nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within seven days, recur, or are accompanied by fever, rash, or persistent headache, medical advice should be sought. A persistent cough may indicate a serious underlying condition, warranting further evaluation. New symptoms that arise during treatment should also prompt a consultation with a healthcare provider.

Side Effects

Patients using this product may experience a range of adverse reactions. Commonly reported side effects include excitability, particularly in children, and marked drowsiness. It is advised that patients avoid alcoholic beverages, as the concomitant use of alcohol, sedatives, and tranquilizers may enhance drowsiness. Caution is recommended when driving a motor vehicle or operating machinery due to the potential for impaired alertness.

In the event that patients experience nervousness, dizziness, or sleeplessness, they should discontinue use and consult a healthcare professional. Additionally, if symptoms do not improve within 7 days, recur, or are accompanied by fever, rash, or persistent headache, medical advice should be sought. A persistent cough may indicate a serious underlying condition, warranting further evaluation.

Patients are also advised to consult a doctor before using this product if they have a chronic cough associated with smoking, asthma, or emphysema, or if the cough is accompanied by excessive phlegm. Other conditions that necessitate medical consultation prior to use include glaucoma, breathing problems such as emphysema or chronic bronchitis, and difficulty urinating due to prostate gland enlargement. Furthermore, individuals taking sedatives or tranquilizers should seek guidance from a healthcare provider or pharmacist before use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Texaclear (allergy relief). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this product. For adolescents aged 12 years and older, the recommended dosage is 1 tablet every 6 to 8 hours.

Caution is advised when administering this product, as excitability may occur, particularly in children, and marked drowsiness may also be experienced. It is important to keep this product out of reach of children.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be vigilant in monitoring for symptoms that may arise from an overdose. While specific symptoms are not detailed in the provided information, it is essential to be aware that they can vary based on the substance involved and the individual patient’s condition.

Management of an overdose typically involves supportive care and symptomatic treatment. The healthcare provider should assess the patient's clinical status and initiate appropriate interventions based on the severity of the symptoms and the specific circumstances of the overdose.

In summary, immediate medical attention is essential in cases of overdose, and healthcare professionals should be prepared to implement necessary management strategies to ensure patient safety and recovery.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use.

Excitability may occur, particularly in children, and marked drowsiness has been observed. The concomitant use of alcohol, sedatives, and tranquilizers may enhance drowsiness.

No information is available regarding carcinogenicity, mutagenicity, or impairment of fertility. Additionally, there is no data provided on animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has revealed reports of several adverse reactions associated with the use of the product. These include drowsiness, excitability—particularly noted in children—nervousness, dizziness, and sleeplessness. These events have been reported voluntarily or identified through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days, recur, or are accompanied by a fever, rash, or persistent headache, they should seek medical advice. A persistent cough may indicate a serious condition, warranting further evaluation. Patients should also be cautioned to report any new symptoms that arise during treatment.

While using this product, patients may experience excitability, particularly in children, and marked drowsiness. It is important to advise patients to avoid alcoholic beverages, as alcohol, sedatives, and tranquilizers can enhance drowsiness. Patients should exercise caution when driving a motor vehicle or operating machinery due to the potential for impaired alertness.

Before initiating treatment, patients should be encouraged to consult a doctor if they have a cough that is chronic or associated with smoking, asthma, or emphysema, or if they have a cough accompanied by excessive phlegm. Those with glaucoma, breathing problems such as emphysema or chronic bronchitis, or difficulty urinating due to prostate enlargement should also seek medical advice prior to use. Furthermore, patients taking sedatives or tranquilizers should consult a doctor or pharmacist before using this product.

Storage and Handling

The product is supplied in a child-resistant package designed to ensure safety. It is important to note that the product should not be used if the foil seal under the cap is broken or missing, as this indicates potential tampering.

For optimal storage, the product should be kept at room temperature, specifically within the range of 20-30°C (68-86°F). Care should be taken to avoid exposure to excess heat and humidity, as these conditions may compromise the integrity of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Texaclear, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)